Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.

MLA

Groh, Matthieu, et al. “Involvement of the JAK-STAT Pathway in the Molecular Landscape of Tyrosine Kinase Fusion-Negative Hypereosinophilic Syndromes: A Nationwide CEREO Study.” American Journal of Hematology, vol. 99, no. 6, June 2024, pp. 1108–18. EBSCOhost, https://doi.org/10.1002/ajh.27306.

APA

Groh, M., Fenwarth, L., Labro, M., Boudry, A., Fournier, E., Wemeau, M., Marceau-Renaut, A., Daltro de Oliveira, R., Abraham, J., Barry, M., Blanche, P., Bodard, Q., Braun, T., Chebrek, S., Decamp, M., Durel, C.-A., Forcade, E., Gerfaud-Valentin, M., Golfier, C., … Duployez, N. (2024). Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study. American Journal of Hematology, 99(6), 1108–1118. https://doi.org/10.1002/ajh.27306

Chicago

Groh, Matthieu, Laurène Fenwarth, Mathilde Labro, Augustin Boudry, Elise Fournier, Mathieu Wemeau, Alice Marceau-Renaut, et al. 2024. “Involvement of the JAK-STAT Pathway in the Molecular Landscape of Tyrosine Kinase Fusion-Negative Hypereosinophilic Syndromes: A Nationwide CEREO Study.” American Journal of Hematology 99 (6): 1108–18. doi:10.1002/ajh.27306.